SANUWAVE Health (SNWV) EBITDA (2010 - 2026)

SANUWAVE Health (SNWV) has 17 years of EBITDA data on file, last reported at -$1.1 million in Q1 2026.

• On a quarterly basis, EBITDA fell 287.02% year-over-year to -$1.1 million in Q1 2026; TTM through Mar 2026 was $3.2 million, a 43.93% decrease from a year earlier, with the FY2025 full-year figure at $4.9 million, up 28.51% from the prior year.
• EBITDA for Q1 2026 stood at -$1.1 million, down from $2.0 million in the prior quarter.
• Over the last five years, EBITDA for SNWV reached as high as $2.0 million in Q4 2024 and fell as low as -$3.0 million in Q2 2022.
• Historically, EBITDA has averaged -$107176.5 across 5 years, with a median of $601000.0 in 2025.
• Across the five-year window, EBITDA surged 379.28% in 2024 and tumbled 287.02% in 2026, its largest moves.
• Year by year, EBITDA stood at -$1.5 million in 2022, then soared by 171.02% to $1.0 million in 2023, then surged by 93.65% to $2.0 million in 2024, then retreated by 0.45% to $2.0 million in 2025, then sank by 156.12% to -$1.1 million in 2026.
• Per Business Quant data, the three most recent EBITDA figures were -$1.1 million in Q1 2026, $2.0 million in Q4 2025, and $903000.0 in Q3 2025.